GENEVA, May 29, 2024 /PRNewswire/ -- During the World health Assembly today, Eli Lilly and Company (NYSE: LLY ) announced it will donate $6.5 million to the United States Fund for UNICEF to expand UNICEF's work to improve the health outcomes of millions of children and youth at risk of noncommunicable disease s (NCDs) living in resource-limited settings in India. This will bring the company's total commitment since 2022 to more than $20 million.
With this additional funding, UNICEF will seek to improve efforts to address NCD risk factors, strengthen health systems, enhance the ability of health workers to care for people and support millions of children and their families challenged by disease s like type 1 diabetes , respiratory illnesses, rheumatic and congenital heart disease , and sickle cell disease in resource-limited areas in India. "UNICEF will work with governments and partners to strengthen health systems to effectively manage NCDs in children and young people. This will help integrate efforts into maternal, newborn, and child health programs, emphasizing prevention and management of childhood NCDs," says Luigi D'Aquino, chief of health , UNICEF India.
Noncommunicable disease s place a significant burden on economies while being closely linked to poverty, poor social and economic development, and other inequities. This burden is disproportionately felt by low-income countries, communities, and the most vulnerable people, including children and adolescents. Childhood.
